1-6 of 6
Authors: Thomas Angelini
Journal Article
CNSC-17. UPREGULATION OF CCL4 AFTER TREATMENT WITH A NOVEL MRNA VACCINE SHIFTS THE PHENOTYPE OF CCR5-EXPRESSING MICROGLIA WITHIN TUMOR MICROENVIRONMENT
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii44, https://doi.org/10.1093/neuonc/noae165.0173
Published: 11 November 2024
Journal Article
CNSC-30. CD4 T CELLS MEDIATED UPREGULATION OF CCL4 CHEMOKINE DRIVES GLIOBLASTOMA TUMOR MICROENVIRONMENT REPROGRAMMING FOLLOWING TREATMENT WITH A NOVEL MRNA VACCINE
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v29, https://doi.org/10.1093/neuonc/noad179.0114
Published: 10 November 2023
Journal Article
IMMU-33. CCL4 DRIVES GLIOBLASTOMA (GBM) TUMOR MICROENVIRONMENT (TME) REPROGRAMMING AFTER TREATMENT WITH A NOVEL MRNA VACCINE
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii138, https://doi.org/10.1093/neuonc/noac209.530
Published: 14 November 2022
Journal Article
DDDR-29. THE HYDROGEL-CXCL9-MRNA (HCM) VACCINE RESULTS IN SIGNIFICANT ANTI-TUMOR EFFICACY THROUGH RECRUITMENT OF NATURAL KILLER (NK) CELLS
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii105, https://doi.org/10.1093/neuonc/noac209.394
Published: 14 November 2022
Journal Article
IMMU-20. HYDROGEL-CXCL9 VACCINE RESULTS IN MRNA DELIVERY TO DENDRITIC CELLS AND POTENT ANTI-TUMOR RESPONSES IN GBM
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi96, https://doi.org/10.1093/neuonc/noab196.379
Published: 12 November 2021
Journal Article
BSTM-03. INCREASING ANTI-TUMOR T CELL ACTIVATION, VELOCITY, AND MIGRATION TO BRAIN STEM GLIOMA USING HEMATOPOIETIC STEM AND PROGENITOR CELLS
Neuro-Oncology, Volume 21, Issue Supplement_2, April 2019, Page ii67, https://doi.org/10.1093/neuonc/noz036.020
Published: 23 April 2019
